+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on Google+Follow on Google+
Follow on LinkedInFollow on LinkedIn

+ Translate

Prospective evaluation of risk of cervical cancer after cytological evidence of human papillomavirus infection

Lancet 1(8481): 573-575

Prospective evaluation of risk of cervical cancer after cytological evidence of human papillomavirus infection

846 women with cytological evidence of human papillomavirus infection on their Papanicolaou smears in 1979 were followed for the subsequent development of cervical malignant disorders. Carcinoma-in-situ developed in 30 women during the next 6 years, compared with an expected number of 1.9 by general population incidence figures, giving a relative risk of 15.6. The risk was greatly increased (38.7) in women younger than 25 years when the cytological diagnosis of human papillomavirus infection was made.

Accession: 006206004

PMID: 2869301

DOI: 10.1016/S0140-6736(86)92807-2

Download PDF Full Text: Prospective evaluation of risk of cervical cancer after cytological evidence of human papillomavirus infection

Related references

Prospective Evaluation of Risk of Cervical Cancer after Cytological Evidence of Human Papillomavirus. Obstetric and Gynecologic Survey 42(1): 62-63, 1987

Epidemiological study of high-risk human papillomavirus infection in subjects with abnormal cytological findings in cervical cancer screening. Experimental and Therapeutic Medicine 15(1): 412-418, 2018

Prospective seroepidemiologic study of human papillomavirus infection as a risk factor for invasive cervical cancer. Journal of the National Cancer Institute 89(17): 1293-1299, 1997

Multiple human papillomavirus infection with or without type 16 and risk of cervical intraepithelial neoplasia among women with cervical cytological abnormalities. Cancer Causes & Control 25(12): 1669-1676, 2016

Prevalence of high risk human papillomavirus infection with different cervical cytological features among women undergoing health examination at the National Cancer Institute, Thailand. Asian Pacific Journal of Cancer Prevention 15(14): 5879-5882, 2015

Histological and cytological evidence of viral infection and human papillomavirus type 16 dna sequences in cervical intraepithelial neoplasia and normal tissue in the west of scotland uk evaluation of treatment policy. British Medical Journal 296(6619): 381-385, 1988

Prevalence of human papillomavirus infection and risk of cervical cancer or precancerous lesions in 15 years follow up: a prospective cohort study. Zhonghua Zhong Liu Za Zhi 38(10): 792-797, 2016

No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with human papillomavirus 16/18 infection. Cancer Research 58(20): 4585-4586, 1998

High-Risk Human Papillomavirus (HPV) Infection and Cervical Cancer Prevention in Britain: Evidence of Differential Uptake of Interventions from a Probability Survey. Cancer Epidemiology, Biomarkers & Prevention 24(5): 842-853, 2016

MBL2 gene polymorphisms are correlated with high-risk human papillomavirus infection but not with human papillomavirus-related cervical cancer. Human Immunology 70(6): 436-439, 2009